Polymyalgia rheumatica-like syndrome from checkpoint inhibitor therapy: case series and systematic review of the literature
Objective To assess whether the polymyalgia rheumatica (PMR)-like syndrome reported as an immune related adverse event (irAE) from checkpoint inhibitor therapy is consistent with the 2012 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) provisional criteria for PMR.M...
Hlavní autoři: | , , , , , |
---|---|
Médium: | Článek |
Jazyk: | English |
Vydáno: |
BMJ Publishing Group
2019-06-01
|
Edice: | RMD Open |
On-line přístup: | https://rmdopen.bmj.com/content/5/1/e000906.full |